Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Management of Venous Thromboembolism
Author(s): Nazli Okumus , Ashley Park , Eugene Yuridistky , et al Added: 1 year ago

Anticoagulation

Vascular Disease and Surgery
ESC 25: ESVM Guidelines on Interventional Treatment of VTE
Author(s): Oliver Schlager Added: 7 months ago
ESC Congress 2025 - New guidelines for catheter-based VTE therapy emphasise the importance of involving vascular experts, and performing procedures in experienced centers.Dr Oliver Schlager (Medical University of Vienna, AT) joins us to discuss the newly released 2025 ESVM Guidelines on Interventional Treatment of Venous Thromboembolism, endorsed by European national societies of Vascular… View more

Guidelines & Statements

Intervention
ESC 25: The HI-PRO Trial
Author(s): Gregory Piazza Added: 7 months ago
ESC Congress 2025 - HI-PRO shows apixaban 2.5mg twice daily reduced the risk of symptomatic recurrent venous thromboembolism when compared to placebo at 12 months.Dr Gregory Piazza (Brigham and Women's Hospital, US) joins us to discuss findings from the HI-PRO trial, evaluating extended-duration low-intensity apixaban versus placebo for secondary prevention in high-risk patients with provoked… View more

Anticoagulation

Vascular Disease and Surgery
Line Melgaard
Research Area(s) / Expertise:
Dr Line Melgaard MSc, PhD graduated from the University of Aalborg in 2013 with a master degree in Medicine with Industrial Specialization. Dr Melgaard received a PhD-degree from Aalborg University in 2016 (title: “Thromboembolic risk in heart failure patients without atrial fibrillation”). During her PhD, she used Danish nationwide registry data to investigate predictors of ischemic stroke and… View more
ACC 25 Late-Breaking Discussion: The API-Cat Study
Author(s): Harriette Van Spall , Isabelle Mahé Added: 1 year ago
ACC 25 - The API-CAT Study shows reduced-dose apixaban is non-inferior to full-dose apixaban for extended anticoagulation in patients with active cancer who have completed 6 months of anticoagulant therapy for venous thromboembolism (VTE).Late-Breaker host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Prof Isabelle Mahe (Paris Cite University, Paris, FR) to discuss the… View more

Anticoagulation

Vascular Disease and Surgery
Job title: Professor of Medicine in the Division of Pulmonary and Critical Care Medicine
3 Trials That Will Change My Practice with Dr Deepak Bhatt
Author(s): Deepak L Bhatt Added: 3 weeks ago
ACC 2026 — Dr Deepak Bhatt (Mount Sinai Fuster Heart Hospital, US) delivers his expert verdict on three late-breaking clinical trials from ACC 2026 that are poised to influence cardiovascular care and future clinical guidelines.Dr Bhatt highlights data updates from the SURPASS-CVOT trial, exploring expanded cardiometabolic findings with tirzepatide versus dulaglutide, discusses the HI-PEITHO… View more

Intervention

Anticoagulation
Job title: Clinical Cardiologist and Professor of Vascular Biology
Job title: Professor of Angiology / Director University Clinic of Angiology
Prof Nils Kucher is aProfessor of Angiology and Director University Clinic of Angiology at University Hospital Zürich, Zürich, CH. He specialises in minimally invasive endovascular treatment of acute pulmonary embolism, acute deep vein thrombosis, and the post-thrombotic syndrome. From 2016-2017 he was Chief Physician of Angiology at University Hospital Bern, where earlier he fulfilled the… View more
Job title: Associate Professor of Cardiovascular Surgery
Dr Mert Dumantepe is an Associate Professor of Cardiovascular Surgery at Acibadem University School of Medicine, Turkey. He completed his graduation from Istanbul University School of Medicine, Turkey in 2001. He did a fellowship in chronic thromboembolic pulmonary hypertension and pulmonary endarterectomy and the heart transplantation and mechanical asist device programme at the University of… View more